Konica Minolta Unloads Ambry Medical Unit for $600 Million.

Tonernews.com, November 7, 2024. USA

This topic is empty.

Viewing 1 post (of 1 total)

Author

Posts
#562336

toner
Keymaster

Konica Minolta Unloads Ambry Medical Unit for $600 Million.
Debevoise & Plimpton LLP is representing Konica Minolta in the sale of its subsidiary, Ambry Genetics, to Tempus AI (NASDAQ: TEM). Under the terms of the deal, Tempus will acquire Ambry for $375 million in cash and $225 million in Tempus shares at closing, with $100 million of the shares subject to a one-year lock-up period.

For additional details, please refer to the company’s press release.

Ambry Genetics is a leading provider of genetic testing services, while Tempus AI is a technology-driven company focused on advancing precision medicine through the application of artificial intelligence in healthcare.
Author

November 7, 2024 at 3:43 PM

Viewing 1 post (of 1 total)

You must be logged in to reply to this topic.

The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty, or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action based on the content on our site.